Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

  • EU PE&PV research network
  • Specific Contract 02 implementing Framework service contract EMA/2018/23/PE

Full title

Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines in context of thrombosis with thrombocytopenia syndrome (TTS): risk awareness and adherence (RiskAwareTTS) 

Principal investigator

Dr. Teresa Meneses Leonardo Alves, RIVM - project coordinator
Prof. Dr. Olaf Klungel, Utrecht 木瓜福利影视, EU PE&PV lead

Participating organisations

  • Utrecht 木瓜福利影视, The Netherlands - consortium lead
  • RIVM, The Netherlands - coordinator
  • 木瓜福利影视 of Copenhagen, Denmark
  • 木瓜福利影视 of Porto, Portugal
  • Democritus 木瓜福利影视 of Thrace, Greece
  • R墨ga Stradi艈拧 木瓜福利影视, Latvia
  • 木瓜福利影视 of Ljubljana, Faculty of Pharmacy, Slovenia 

Status

Completed (2023)

Deliverables

  • Full study report will be available soon

Peer-reviewed scientific publications

  • . Buhl C, Jacobsen R, Almarsd贸ttir AB, Abtahi S, Andersen A, Deligianni E, Dermiki-Gkana F, Kontogiorgis C, Oikonomou C, Kursite M, Poplavska E, Hegger I, van der Goot M, Sousa Ferreira PB, Ribeiro-Vaz I, Silva AM, Kos M, Lipovec N膶, van Vliet E, Alves TL. Vaccine. 2024 Jan 4:S0264-410X(23)01511-6. doi: 10.1016/j.vaccine.2023.12.065. Epub ahead of print. PMID: 38182460.
  • . van Vliet E, Lipovec N膶, van der Goot M, Abtahi S, Ribeiro-Vaz I, Poplavska E, Dermiki-Gkana F, Oikonomou C, Deligianni E, Kontogiorgis C, Silva AM, Ferreira PBS, Kos M, Almarsd贸ttir AB, Jacobsen R, Buhl C, de Bruijn A, Hegger I, Alves TL.  Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70057. doi: 10.1002/pds.70057. PMID: 39586738; PMCID: PMC11589195.